USPTO serial 79273453
MP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 28, 2021
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kristen Ruisi
Kristen Ruisi Venable LLP151 West 42nd Street, 49th FloorNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemicals additives for use in the manufacture of pharmaceuticals in the pharmaceutical industry; chemicals for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for use in the manufacture of pharmaceuticals for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical additives for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical and veterinary preparations, namely contraceptive preparations and substances; sanitary preparations for medical purposes; sterilizing preparations; hormone replacement therapy preparations; dietetic foods adapted for medical or veterinary use; dietetic substances, namely dietetic sugar and sugar substitutes for medical use, dietetic infusions for medical use, dietetic preparations for medical purposes, dietetic beverages for medical purposes; food for babies; medicated supplements for foodstuffs for babies; dietary supplements for humans and animals; plasters for medical purposes; materials for dressings, namely, bandages for dressings, gauze for dressings, wadding for dressings, and transparent film for dressings; material for stopping teeth, dental wax; dietary supplements for humans and dietetic preparations adapted for medical purposes, and dietary supplements for animals; dental preparations, namely, dental preparations for disclosing plaque and tartar on the teeth, anti-cavity dental coating preparations containing fluoride, dental varnish for use by dentists, dental compounds used in endodontic procedures, dental abrasives; dental articles, namely, prefilled dental trays for applying dental compositions to teeth, materials for making dental impressions, materials for dental use for fillings, material for dental crowns, material for dental bridges, amalgam for dental purposes, dental sealants, dental resin cement, dental hemostatic paste, dental adhesives, medicated dental rinses, dental blanks, bonding and primer materials for dental purposes, dental polish, dental veneers for use in dental restoration; anesthetics; analgesics; bone cement for surgical and orthopedic purposes; capsules for medicines, namely, capsules sold empty for pharmaceuticals, decongestant capsules, allergy capsules; medical and veterinary preparations for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and articles, namely, enzyme preparations for medical purposes and surgical implants comprised of living tissue, diagnostic preparations for medical purposes, pharmaceuticals, namely, for use in the prevention treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, and natural remedies, namely, natural remedy preparation for the prevention and treatment for the treatment viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, medical dressings, medical coverings for dressings used to cover and treat wounds and burns and medical applicators for the treatment of wounds and burns; hygienic preparations and articles, namely, disinfectants for hygiene purposes and antiseptics, all-purpose deodorizers preparations for household, commercial and industrial use and air purifiers preparations, absorbent articles for personal hygiene, namely, pants, sanitary pads and absorbents for incontinence; disinfectants; preparations for destroying vermin; fungicides, herbicides; pest control preparations, namely, insecticides and poisons for domestic and agricultural use, and articles, namely, freeze dried food bait for pest control purposes, granular repellent for burrowing pests; drug delivery agents in the form of tablets, capsules, suppositories, dissolvable films, coatings for tablets, compounds, edible wafers for wrapping powdered pharmaceuticals that facilitate the deferred, controlled or immediate release of active substances of pharmaceutical preparations | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dental apparatus and instruments, namely, dental drills, dental drill bits, milling apparatus for dental purposes, dental root files, sprayers for cleaning the teeth and gums used in dentists' offices, oral irrigators, dental clips, bite trays, dental impression trays, prophy angles, apex locators, intra-oral dental light systems, dental picks, dental operating lamps, prosthetic instruments for dental purposes, forceps for dental technical purposes, and teeth protectors; implant bridges for dental purposes; implant abutments for dental purposes; Orthodontic machines and instruments for dental purposes; veterinary apparatus and instruments for use in the prevention and treatment of viral, bacterial, metabolic, endocrine, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in animals; bracelets for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes used in the testing and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical products, namely, intravaginal drug delivery devices sold empty for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; medical products, namely, implantable subcutaneous drug delivery devices sold empty for hormone replacement therapy products; medical products, namely, intravaginal drug delivery devices sold empty for hormone replacement therapy products; intra vaginal ring sold empty for delivery of hormone replacement therapy products by a continuous release system; inhalers for medical use; hearing protection devices, namely, hearing protectors without the ability to reproduce or transmit sound; feeding aids, namely, disposable teats being pacifiers for babies and dishes adapted for feeding babies and children; pacifiers for babies; contraceptive devices, namely, condoms, intra-uterine contraceptive devices, diaphragms for contraception, and medical implants for contraceptive purposes; syringes for injections and for medical purposes; medical apparatus, namely, medical measuring apparatus, being those that can directly transmit data to a database, particularly thermometers for medical use, pulse meters, and medical diagnostic apparatus for measuring respiratory rates and sleeping conditions; medical and veterinary monitoring apparatus and instruments, namely, for use in monitoring vital signs of patients, oxygen monitors, electronic temperature monitors; all parts and fittings of all the aforesaid goods | ACTIVE | — |
| 042 | Medical research services in the field of or for use in the field of the prevention and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and pharmacological research services; scientific and technological research services relating to viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hematological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Millicent Pharma Limited
- Other trademarks owned by Millicent Pharma Limited
- Other trademarks owned by Millicent Pharma Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named MP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 18, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 18, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Aug 18, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 18, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 10, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 9, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 28, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 24, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 22, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 22, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 22, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 3, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Sep 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 1, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 10, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 23, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 5, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 5, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 2, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 4, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 4, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 4, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 4, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 4, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 4, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 10, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 10, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 10, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 10, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 1, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 15, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 14, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 13, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |